Nifedipine Induces FAM20A Upregulation and LRP2/CUBN‐Mediated Fetuin‐A Accumulation in Gingival Overgrowth
Authors:
- Isaac De la RosaIRIsaac De la Rosa
- Amina BakerABAmina Baker
- Vidjeacoumary CannayaVCVidjeacoumary Cannaya
- Erika Rodríguez-CavalloERErika Rodríguez-Cavallo
- Darío Méndez-CuadroDMDarío Méndez-Cuadro
- Jaime Plazas-RomanJPJaime Plazas-Roman
- Víctor Simancas-EscorciaVSVíctor Simancas-Escorcia
- Antonio Diaz-CaballeroADAntonio Diaz-Caballero
- Renata KozyrakiRKRenata Kozyraki
Open Access
- 1 January 2026
- journal article
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1)
Abstract
Aim: Nifedipine‐induced gingival overgrowth (NIGO) has been linked to fibrotic remodeling of the gingiva, yet whether FAM20A and Fetuin‐A contribute to this process is unknown. Here we ask whether their expression is altered in NIGO and, if so, whether nifedipine itself drives this change. Material and Methods: We examined gingival biopsies from 18 patients under long‐term nifedipine treatment and 17 unaffected controls by immunofluorescence, western blotting, and RT‐qPCR. In parallel, human gingival fibroblasts (hGF) were exposed to 100 ng/mL nifedipine for either 48 h or 7 days to test for direct drug effects on FAM20A, FAM20C, Fetuin‐A, alpha‐smooth muscle actin (α‐SMA), and the endocytic receptors LRP2 and CUBN. Protein expression was graded semiquantitatively, and group differences were considered significant at p < 0.05. Results: Both FAM20A and Fetuin‐A were markedly overexpressed in fibrotic NIGO gingiva. Nifedipine exposure raised FAM20A expression in hGF, yet left Fetuin‐A unchanged at either the transcript or protein level—an apparent contradiction that prompted us to examine its receptors, LRP2 and CUBN. These were barely detectable in healthy gingiva but abundant in NIGO tissue, where Fetuin‐A colocalized with LRP2; nifedipine reproduced this induction of LRP2/CUBN in cultured hGF. Together, these findings point to enhanced Fetuin‐A endocytosis, rather than increased synthesis, as the source of its accumulation in NIGO. TGFβ signaling was not activated under any nifedipine treatment condition tested. Conclusion: FAM20A, Fetuin‐A, and the LRP2/CUBN endocytic pair emerge as central molecular players in NIGO. Our data indicate that nifedipine drives FAM20A upregulation and boosts LRP2/CUBN‐dependent Fetuin‐A uptake through a TGFβ‐independent route, offering a new mechanistic view of NIGO and pointing to candidate targets for future therapeutic strategies.Keywords
Funding Information
- Sorbonne Université
- Institut National de la Santé et de la Recherche Médicale
- Université de Paris
This publication has 46 references indexed in Scilit:
- Fetuin‐A adsorption to tunable polydimethylsiloxane and subsequent macrophage responseJournal of Biomedical Materials Research Part A, 2023
- Genetic Variability in the Iron Homeostasis Pathway and Patient Outcomes After Aneurysmal Subarachnoid HemorrhageNeurocritical Care, 2020
- Two new families with enamel renal syndrome: A novel FAM20A gene mutation and review of literatureEuropean Journal of Medical Genetics, 2020
- Physical attributes of salivary calcium particles and their interaction with gingival epitheliumBiomedical Journal, 2020
- Association of AHSG gene polymorphisms with serum Fetuin-A levels in individuals with cardiovascular calcification in west of IranMolecular Biology Reports, 2020
- Clinical implications of fetuin-A2019
- MyofibroblastsExperimental Eye Research, 2016
- Physicochemical and Biological Properties of Biomimetic Mineralo‐Protein Nanoparticles Formed Spontaneously in Biological FluidsSmall, 2012
- The “thrifty” gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistanceCellular Signalling, 2011
- Pharmacokinetics and Pharmacodynamics of Nifedipine in Patients at Steady StateThe Journal of Clinical Pharmacology, 1986